Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

NASH
Source:

Team

Learn more about the team from BioxyTran

Investors

Learn more about BioxyTran investors and S1 Stocks

Forum

Join the conversation as we discuss Bioxytran's use-cases,
development progress, and more.